Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Vacher, Sophie"'
Autor:
Shen WW; Institut Curie - Centre de Recherche, PSL Research University, Membrane Dynamics and Mechanics of Intracellular Signaling team, 75248, Paris, cedex 05, France.; Institut National de la Santé et de la Recherche Médicale (INSERM), U1143, Paris, France.; Centre National de la Recherche Scientifique (CNRS), UMR, 3666, Paris, France., Bièche I; Pharmacogenomics Unit, Department of Genetics, Institut Curie, 26 rue d'Ulm, 75248, Paris, cedex 05, France., Fuhrmann L; Department of Pathology, Institut Curie, 26 rue d'Ulm, 75248, Paris, cedex 05, France., Vacher S; Pharmacogenomics Unit, Department of Genetics, Institut Curie, 26 rue d'Ulm, 75248, Paris, cedex 05, France., Vincent-Salomon A; Pharmacogenomics Unit, Department of Genetics, Institut Curie, 26 rue d'Ulm, 75248, Paris, cedex 05, France.; Institut Curie, PSL Research University, INSERM U830, 26 rue d'Ulm, 75248, Paris, cedex 05, France., Torrino S; CNRS UMR7275, Institut de Pharmacologie Cellulaire et Moléculaire, Université Côte d'Azur, 06560, Valbonne, France. stephanie.torrino@unice.fr., Lamaze C; Institut Curie - Centre de Recherche, PSL Research University, Membrane Dynamics and Mechanics of Intracellular Signaling team, 75248, Paris, cedex 05, France. christophe.lamaze@curie.fr.; Institut National de la Santé et de la Recherche Médicale (INSERM), U1143, Paris, France. christophe.lamaze@curie.fr.; Centre National de la Recherche Scientifique (CNRS), UMR, 3666, Paris, France. christophe.lamaze@curie.fr.
Publikováno v:
Scientific reports [Sci Rep] 2020 May 14; Vol. 10 (1), pp. 7998. Date of Electronic Publication: 2020 May 14.
Autor:
Lallemand F; Service de génétique, unité de pharmacogénomique, Institut Curie, 26 rue d'Ulm, Paris, France.; Paris Sciences Lettres Research University, Paris, France., Vacher S; Service de génétique, unité de pharmacogénomique, Institut Curie, 26 rue d'Ulm, Paris, France.; Paris Sciences Lettres Research University, Paris, France., de Koning L; Translational Research Department, Institut Curie, PSL Research University, 26 rue d'Ulm, Paris, France., Petitalot A; Service de génétique, unité de pharmacogénomique, Institut Curie, 26 rue d'Ulm, Paris, France.; Paris Sciences Lettres Research University, Paris, France.; Service de génétique, unité de génétique constitutionnelle, Institut Curie, 26 rue d'Ulm, Paris, France., Briaux A; Service de génétique, unité de pharmacogénomique, Institut Curie, 26 rue d'Ulm, Paris, France.; Paris Sciences Lettres Research University, Paris, France., Driouch K; Service de génétique, unité de pharmacogénomique, Institut Curie, 26 rue d'Ulm, Paris, France.; Paris Sciences Lettres Research University, Paris, France., Callens C; Service de génétique, unité de pharmacogénomique, Institut Curie, 26 rue d'Ulm, Paris, France.; Paris Sciences Lettres Research University, Paris, France., Schnitzler A; Service de génétique, unité de pharmacogénomique, Institut Curie, 26 rue d'Ulm, Paris, France.; Paris Sciences Lettres Research University, Paris, France., Lecerf C; Translational Research Department, Institut Curie, PSL Research University, 26 rue d'Ulm, Paris, France., Oulie-Bard F; Translational Research Department, Institut Curie, PSL Research University, 26 rue d'Ulm, Paris, France., Barbet A; Translational Research Department, Institut Curie, PSL Research University, 26 rue d'Ulm, Paris, France., Vincent A; Centre de Recherche en Cancérologie de Lyon (CRCL)/INSERM U1052-CNRS UMR5286 Centre Léon Bérard, 28 Rue Laënnec, 69373 Cedex 08, Lyon, France., Lyon, France., Zinn-Justin S; Laboratoire de Biologie Structurale et Radiobiologie, Institute for Integrative Biology of the Cell (CEA, CNRS, University Paris South), University Paris-Saclay, Gif-sur-Yvette, France., Lopez BS; CNRS UMR 8200, Gustave Roussy Cancer Institute, Université Paris-Saclay, équipe labélisée par la Ligue contre le cancer, Villejuif, France.; Institut Cochin, INSERM U1016, UMR 8104 CNRS, Université de Paris, 75014, Paris, France., Lidereau R; Service de génétique, unité de pharmacogénomique, Institut Curie, 26 rue d'Ulm, Paris, France., Bieche I; Service de génétique, unité de pharmacogénomique, Institut Curie, 26 rue d'Ulm, Paris, France.; INSERM U1016, Université Paris Descartes, 4 avenue de l'observatoire, Paris, France., Caputo SM; Paris Sciences Lettres Research University, Paris, France. sandrine.caputo@curie.fr.; Service de génétique, unité de génétique constitutionnelle, Institut Curie, 26 rue d'Ulm, Paris, France. sandrine.caputo@curie.fr.
Publikováno v:
Scientific reports [Sci Rep] 2020 Apr 24; Vol. 10 (1), pp. 6920. Date of Electronic Publication: 2020 Apr 24.
Autor:
Leblanc O; Department of Genetics, Curie Institute, PSL Research University, Paris 75005, France., Vacher S; Department of Genetics, Curie Institute, PSL Research University, Paris 75005, France., Lecerf C; Department of Drug Development and Innovation (D3i), Curie Institute, PSL Research University, Paris 75005, France., Jeannot E; Department of Genetics, Curie Institute, PSL Research University, Paris 75005, France.; Department of Pathology, Curie Institute, PSL Research University, Paris 75005, France., Klijanienko J; Department of Pathology, Curie Institute, PSL Research University, Paris 75005, France., Berger F; Department of Biostatistics, Curie Institute, PSL Research University, Paris 75005, France., Hoffmann C; Department of Surgery, Curie Institute, PSL Research University, Paris 75005, France.; INSERM U932 Research Unit, Paris 75005, France., Calugaru V; Department of Radiotherapy, Curie Institute, PSL Research University, Paris 75005, France., Badois N; Department of Surgery, Curie Institute, PSL Research University, Paris 75005, France., Chilles A; Department of Radiotherapy, Curie Institute, PSL Research University, Paris 75005, France., Lesnik M; Department of Surgery, Curie Institute, PSL Research University, Paris 75005, France., Krhili S; Department of Surgery, Curie Institute, PSL Research University, Paris 75005, France., Bieche I; Department of Genetics, Curie Institute, PSL Research University, Paris 75005, France.; EA7331, Faculty of Pharmaceutical and Biological Sciences, Paris Descartes University, Paris 75005, France., Le Tourneau C; Department of Drug Development and Innovation (D3i), Curie Institute, PSL Research University, Paris 75005, France.; INSERM U900 Research Unit, Curie Institute, Paris 75005, France., Kamal M; Department of Drug Development and Innovation (D3i), Curie Institute, PSL Research University, Paris 75005, France.
Publikováno v:
Cancer biology & medicine [Cancer Biol Med] 2020 Feb 15; Vol. 17 (1), pp. 208-217.
Autor:
Lecerf C; Department of Drug Development and Innovation, Institut Curie, Paris & Saint-Cloud, France. Electronic address: charlotte.lecerf@curie.fr., Kamal M; Department of Drug Development and Innovation, Institut Curie, Paris & Saint-Cloud, France. Electronic address: maud.kamal@curie.fr., Vacher S; Department of Genetics, Institut Curie, PSL Research University, Paris, France. Electronic address: sophie.vacher@curie.fr., Chemlali W; Department of Genetics, Institut Curie, PSL Research University, Paris, France. Electronic address: walid.chemlali@curie.fr., Schnitzler A; Department of Genetics, Institut Curie, PSL Research University, Paris, France. Electronic address: anne.schnitzler@curie.fr., Morel C; Department of Drug Development and Innovation, Institut Curie, Paris & Saint-Cloud, France. Electronic address: claire.morel@curie.fr., Dubot C; Department of Drug Development and Innovation, Institut Curie, Paris & Saint-Cloud, France. Electronic address: coraline.dubot@curie.fr., Jeannot E; Department of Genetics, Institut Curie, PSL Research University, Paris, France; Department of Pathology, Institut Curie, PSL Research University, Paris, France. Electronic address: emmanuelle.jeannot@curie.fr., Meseure D; Department of Pathology, Institut Curie, PSL Research University, Paris, France. Electronic address: didier.meseure@curie.fr., Klijanienko J; Department of Pathology, Institut Curie, PSL Research University, Paris, France. Electronic address: jerzy.klijanienko@curie.fr., Mariani O; Department of Pathology, Institut Curie, PSL Research University, Paris, France. Electronic address: Odette.mariani@curie.fr., Borcoman E; INSERM U932 Research Unit, Institut Curie, PSL Research University, Paris, France. Electronic address: edith.borcoman@curie.fr., Calugaru V; Department of Radiotherapy, Institut Curie, PSL Research University, Paris, France. Electronic address: valentin.calugaru@curie.fr., Badois N; Department of Surgery, Institut Curie, PSL Research University, Paris, France. Electronic address: nathalie.badois@curie.fr., Chilles A; Department of Radiotherapy, Institut Curie, PSL Research University, Paris, France. Electronic address: anne.chilles@curie.frm., Lesnik M; Department of Surgery, Institut Curie, PSL Research University, Paris, France. Electronic address: maria.lesnik@curie.fr., Krhili S; Department of Surgery, Institut Curie, PSL Research University, Paris, France. Electronic address: samar.krhili@curie.fr., Choussy O; Department of Surgery, Institut Curie, PSL Research University, Paris, France. Electronic address: olivier.choussy@curie.fr., Hoffmann C; INSERM U932 Research Unit, Institut Curie, PSL Research University, Paris, France; Department of Surgery, Institut Curie, PSL Research University, Paris, France. Electronic address: caroline.hoffmann@curie.fr., Piaggio E; INSERM U932 Research Unit, Institut Curie, PSL Research University, Paris, France. Electronic address: eliane.piaggio@curie.fr., Bieche I; Department of Genetics, Institut Curie, PSL Research University, Paris, France; EA7331, Paris Descartes University, Faculty of Pharmaceutical and Biological Sciences, Paris, France. Electronic address: ivan.bieche@curie.fr., Le Tourneau C; Department of Drug Development and Innovation, Institut Curie, Paris & Saint-Cloud, France; INSERM U900 Research Unit, Institut Curie, Saint-Cloud, France; Versailles-Saint-Quentin-en-Yvelines University, Montigny-le-Bretonneux, France. Electronic address: christophe.letourneau@curie.fr.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2019 Nov; Vol. 121, pp. 210-223. Date of Electronic Publication: 2019 Oct 05.
Autor:
Cabel L; Department of Medical Oncology, Institut Curie, PSL Research University, Paris, Saint Cloud, France. luc.cabel@curie.fr fcbidard@curie.fr.; UVSQ, Paris-Saclay University, Saint Cloud, France., Jeannot E; Department of Pathology and Genetics, Institut Curie, PSL Research University, Paris, Saint Cloud, France., Bieche I; Department of Pathology and Genetics, Institut Curie, PSL Research University, Paris, Saint Cloud, France., Vacher S; Department of Pathology and Genetics, Institut Curie, PSL Research University, Paris, Saint Cloud, France., Callens C; Department of Pathology and Genetics, Institut Curie, PSL Research University, Paris, Saint Cloud, France., Bazire L; Department of Radiotherapy, Institut Curie, PSL Research University, Paris, Saint Cloud, France., Morel A; Department of Medical Oncology, Institut Curie, PSL Research University, Paris, Saint Cloud, France., Bernard-Tessier A; Department of Pathology and Genetics, Institut Curie, PSL Research University, Paris, Saint Cloud, France., Chemlali W; Department of Pathology and Genetics, Institut Curie, PSL Research University, Paris, Saint Cloud, France., Schnitzler A; Department of Pathology and Genetics, Institut Curie, PSL Research University, Paris, Saint Cloud, France., Lièvre A; Department of Gastroenterology, CHU Pontchaillou, Rennes 1 University, Rennes, France., Otz J; Department of Radiotherapy, Institut Curie, PSL Research University, Paris, Saint Cloud, France., Minsat M; Department of Radiotherapy, Institut Curie, PSL Research University, Paris, Saint Cloud, France., Vincent-Salomon A; Department of Pathology and Genetics, Institut Curie, PSL Research University, Paris, Saint Cloud, France., Pierga JY; Department of Medical Oncology, Institut Curie, PSL Research University, Paris, Saint Cloud, France.; Paris Descartes University, Paris, France., Buecher B; Department of Medical Oncology, Institut Curie, PSL Research University, Paris, Saint Cloud, France., Mariani P; Department of Surgery, Institut Curie, PSL Research University, Paris, France., Proudhon C; Circulating Tumor Biomarkers Laboratory, Institut Curie, PSL Research University, Paris, France., Bidard FC; Department of Medical Oncology, Institut Curie, PSL Research University, Paris, Saint Cloud, France. luc.cabel@curie.fr fcbidard@curie.fr.; UVSQ, Paris-Saclay University, Saint Cloud, France.; Circulating Tumor Biomarkers Laboratory, Institut Curie, PSL Research University, Paris, France., Cacheux W; Department of Medical Oncology, Institut Curie, PSL Research University, Paris, Saint Cloud, France.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2018 Nov 15; Vol. 24 (22), pp. 5767-5771. Date of Electronic Publication: 2018 Jul 27.
Autor:
Liang X; Department of Breast Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China.; Pharmacogenomic Unit, Department of Genetics, Curie Institute, PSL Research University, 26 rue d'Ulm, 75005, Paris, France., Vacher S; Pharmacogenomic Unit, Department of Genetics, Curie Institute, PSL Research University, 26 rue d'Ulm, 75005, Paris, France., Boulai A; Pharmacogenomic Unit, Department of Genetics, Curie Institute, PSL Research University, 26 rue d'Ulm, 75005, Paris, France., Bernard V; Clinic bioinformatic Unit, Department of Biopathology, Curie Institute, PSL Research University, Paris, France., Baulande S; Institut Curie Genomics of Excellence (ICGex) Platform, Curie Institute, PSL Research University, Paris, France., Bohec M; Institut Curie Genomics of Excellence (ICGex) Platform, Curie Institute, PSL Research University, Paris, France., Bièche I; Pharmacogenomic Unit, Department of Genetics, Curie Institute, PSL Research University, 26 rue d'Ulm, 75005, Paris, France.; EA7331, Paris Descartes University, Sorbonne Paris Cité, Faculty of Pharmaceutical and Biological Sciences, Paris, France., Lerebours F; Department of Medical Oncology, Curie Institute, René Huguenin Hospital, Saint-Cloud, France., Callens C; Pharmacogenomic Unit, Department of Genetics, Curie Institute, PSL Research University, 26 rue d'Ulm, 75005, Paris, France. celine.callens@curie.fr.
Publikováno v:
Breast cancer research : BCR [Breast Cancer Res] 2018 Aug 07; Vol. 20 (1), pp. 88. Date of Electronic Publication: 2018 Aug 07.
Autor:
Weiswald LB; Division of Gastroenterology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Michael Smith Genome Sciences Center, British Columbia Cancer Agency, Vancouver, British Columbia, Canada., Hasan MR; Division of Gastroenterology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Michael Smith Genome Sciences Center, British Columbia Cancer Agency, Vancouver, British Columbia, Canada., Wong JCT; Division of Gastroenterology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Michael Smith Genome Sciences Center, British Columbia Cancer Agency, Vancouver, British Columbia, Canada., Pasiliao CC; Division of Gastroenterology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Michael Smith Genome Sciences Center, British Columbia Cancer Agency, Vancouver, British Columbia, Canada., Rahman M; Division of Gastroenterology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Michael Smith Genome Sciences Center, British Columbia Cancer Agency, Vancouver, British Columbia, Canada., Ren J; Division of Gastroenterology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Michael Smith Genome Sciences Center, British Columbia Cancer Agency, Vancouver, British Columbia, Canada., Yin Y; Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.; Cancer Surveillance & Outcomes, British Columbia Cancer Agency, Vancouver, British Columbia, Canada., Gusscott S; Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, Canada., Vacher S; Department of Genetics, Institute Curie, Paris, France., Weng AP; Terry Fox Laboratory, British Columbia Cancer Agency, Vancouver, British Columbia, Canada., Kennecke HF; Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada., Bièche I; Department of Genetics, Institute Curie, Paris, France., Schaeffer DF; Department of Pathology, University of British Columbia, Vancouver, British Columbia, Canada., Yapp DT; Experimental Therapeutics, British Columbia Cancer Agency, Vancouver, British Columbia, Canada., Tai IT; Division of Gastroenterology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada. itai@bcgsc.ca.; Michael Smith Genome Sciences Center, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2017 Oct; Vol. 16 (10), pp. 2292-2303. Date of Electronic Publication: 2017 Jun 29.
Autor:
Mameri H; Institut Curie, PSL Research University, UMR 3348, 91405 Orsay, France.; CNRS UMR 3348, Centre Universitaire, Bât. 110, 91405 Orsay, France.; Université Paris Sud, Université Paris-Saclay, UMR 3348, 91405 Orsay, France., Bièche I; Institut Curie, Genetic Department, 26, rue d'Ulm, 75005 Paris, France., Meseure D; Institut Curie, Platform of Investigative Pathology, 26, rue d'Ulm, 75005 Paris, France., Marangoni E; Institut Curie, PSL Research University, Translational Research Department, 26, rue d'Ulm, 75005 Paris, France., Buhagiar-Labarchède G; Institut Curie, PSL Research University, UMR 3348, 91405 Orsay, France.; CNRS UMR 3348, Centre Universitaire, Bât. 110, 91405 Orsay, France.; Université Paris Sud, Université Paris-Saclay, UMR 3348, 91405 Orsay, France., Nicolas A; Institut Curie, Platform of Investigative Pathology, 26, rue d'Ulm, 75005 Paris, France.; Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, 20892., Vacher S; Institut Curie, Genetic Department, 26, rue d'Ulm, 75005 Paris, France., Onclercq-Delic R; Institut Curie, PSL Research University, UMR 3348, 91405 Orsay, France.; CNRS UMR 3348, Centre Universitaire, Bât. 110, 91405 Orsay, France.; Université Paris Sud, Université Paris-Saclay, UMR 3348, 91405 Orsay, France., Rajapakse V; Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, 20892., Varma S; Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, 20892., Reinhold WC; Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, 20892., Pommier Y; Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland, 20892., Amor-Guéret M; Institut Curie, PSL Research University, UMR 3348, 91405 Orsay, France. mounira.amor@curie.fr.; CNRS UMR 3348, Centre Universitaire, Bât. 110, 91405 Orsay, France.; Université Paris Sud, Université Paris-Saclay, UMR 3348, 91405 Orsay, France.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2017 Apr 15; Vol. 23 (8), pp. 2116-2126. Date of Electronic Publication: 2016 Sep 06.
Autor:
Thion MS; Institut Curie, Paris, France.; CNRS UMR 3306, Orsay, France.; INSERM U1005, Orsay, France.; University Paris Sud 11, Orsay, France., Tézenas du Montcel S; Department of Biostatistics and Medical Informatics, Assistance Publique-Hôpitaux de Paris, Paris, France.; Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France.; INSERM, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France., Golmard JL; Department of Biostatistics and Medical Informatics, Assistance Publique-Hôpitaux de Paris, Paris, France., Vacher S; Institut Curie, Paris, France., Barjhoux L; INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France., Sornin V; INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France., Cazeneuve C; Centre de Recherche de l'Institut du Cerveau et de la Moelle épinière, INSERM U975, CNRS UMR7225, UPMC Paris VI UMR S975, Paris, France.; Assistance Publique-Hôpitaux de Paris, Département de Génétique, Centre Hospitalier Universitaire Pitié-Salpêtrière, Paris, France., Bièche I; Institut Curie, Paris, France.; University Paris Descartes, Sorbonne Paris Cité, France., Sinilnikova O; Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Centre Hospitalier Universitaire de Lyon, Centre Léon Bérard, Lyon, France., Stoppa-Lyonnet D; Institut Curie, Paris, France.; Department of Tumour Biology, INSERM U830, Paris, France., Durr A; Centre de Recherche de l'Institut du Cerveau et de la Moelle épinière, INSERM U975, CNRS UMR7225, UPMC Paris VI UMR S975, Paris, France.; Assistance Publique-Hôpitaux de Paris, Département de Génétique, Centre Hospitalier Universitaire Pitié-Salpêtrière, Paris, France., Humbert S; University of Grenoble Alpes, Grenoble Institut des Neurosciences, INSERM U1216, Grenoble, France.; INSERM, U1216, Grenoble, France.
Publikováno v:
European journal of human genetics : EJHG [Eur J Hum Genet] 2016 Aug; Vol. 24 (9), pp. 1310-5. Date of Electronic Publication: 2016 Mar 16.
Autor:
Cizeron-Clairac G; Service de Génétique, Unité de Pharmacogénomique, Institut Curie, 26 rue d'ulm, 75005, Paris, France. geraldine.clairac@gmail.com., Lallemand F; Service de Génétique, Unité de Pharmacogénomique, Institut Curie, 26 rue d'ulm, 75005, Paris, France. francois.lallemand@curie.fr., Vacher S; Service de Génétique, Unité de Pharmacogénomique, Institut Curie, 26 rue d'ulm, 75005, Paris, France. sophie.vacher@curie.fr., Lidereau R; Service de Génétique, Unité de Pharmacogénomique, Institut Curie, 26 rue d'ulm, 75005, Paris, France. rosette.lidereau@curie.fr., Bieche I; Service de Génétique, Unité de Pharmacogénomique, Institut Curie, 26 rue d'ulm, 75005, Paris, France. ivan.bieche@curie.fr., Callens C; Service de Génétique, Unité de Pharmacogénomique, Institut Curie, 26 rue d'ulm, 75005, Paris, France. celine.callens@curie.fr.
Publikováno v:
BMC cancer [BMC Cancer] 2015 Jul 05; Vol. 15, pp. 499. Date of Electronic Publication: 2015 Jul 05.